VYYRF (Voyageur Pharmaceuticals) Total Liabilities: $1.68 Mil (As of Feb. 2026)


VYYRF Voyageur Pharmaceuticals Ltd VYYRF
18 GF Score
Price $0.10
! 5 Warning Signs
View Full Analysis

What is Voyageur Pharmaceuticals Total Liabilities?

Voyageur Pharmaceuticals VYYRF 18 Total Liabilities is $1.68 Mil as of Feb. 2026. GuruFocus rates VYYRF with a GF Score™ of 18/100. The stock has 5 warning signs investors should review.

Voyageur Pharmaceuticals's Total Liabilities for the quarter that ended in Feb. 2026 was $1.68 Mil.

Voyageur Pharmaceuticals's quarterly Total Liabilities declined from Aug. 2025 ($1.62 Mil) to Nov. 2025 ($1.32 Mil) but then increased from Nov. 2025 ($1.32 Mil) to Feb. 2026 ($1.68 Mil).

Voyageur Pharmaceuticals's annual Total Liabilities increased from Nov. 2023 ($0.53 Mil) to Nov. 2024 ($1.54 Mil) but then declined from Nov. 2024 ($1.54 Mil) to Nov. 2025 ($1.32 Mil).


Voyageur Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Voyageur Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals Total Liabilities Chart

Voyageur Pharmaceuticals Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.47 0.53 1.54 1.32

Voyageur Pharmaceuticals Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.47 1.62 1.32 1.68
VYYRF
18GF Score
Voyageur Pharmaceuticals Ltd VYYRF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyageur Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Voyageur Pharmaceuticals's Total Liabilities for the fiscal year that ended in Nov. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.29+(0.028+2.4286128663675E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.32

Total Liabilities=Total Assets (A: Nov. 2025 )-Total Equity (A: Nov. 2025 )
=2.209-0.891
=1.32

Voyageur Pharmaceuticals's Total Liabilities for the quarter that ended in Feb. 2026 is calculated as

Total Liabilities=Total Assets (Q: Feb. 2026 )-Total Equity (Q: Feb. 2026 )
=2.161-0.484
=1.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $1.68 Mil mean?
Voyageur Pharmaceuticals (VYYRF) has a Total Liabilities of $1.68 Mil as of Feb. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Voyageur Pharmaceuticals and its competitors.
Is Voyageur Pharmaceuticals' Total Liabilities too high?
Voyageur Pharmaceuticals' current Total Liabilities is $1.68 Mil. Overall, Voyageur Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' Total Liabilities compare to ZTS and UTHR?
Voyageur Pharmaceuticals' Total Liabilities of $1.68 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Voyageur Pharmaceuticals and its competitors. Voyageur Pharmaceuticals's current Total Liabilities is $1.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current Total Liabilities of $1.68 Mil. The current Total Liabilities is $1.68 Mil. Voyageur Pharmaceuticals' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current Total Liabilities is $1.68 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Voyageur Pharmaceuticals Business Description

Other Exchanges VM:Canada
Address 4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
18GF Score

Get the complete analysis for VYYRF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price